Head-To-Head Analysis: Prenetics Global (PRE) versus The Competition

Prenetics Global (NASDAQ:PRE – Get Free Report) is one of 55 publicly-traded companies in the “Personal Care Products” industry, but how does it compare to its peers? We will compare Prenetics Global to similar companies based on the strength of its analyst recommendations, institutional ownership, profitability, risk, valuation, dividends and earnings.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Prenetics Global and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prenetics Global 1 0 6 1 2.88
Prenetics Global Competitors 908 2952 3666 229 2.41

Prenetics Global presently has a consensus target price of $37.17, indicating a potential upside of 259.10%. As a group, “Personal Care Products” companies have a potential upside of 4.06%. Given Prenetics Global’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Prenetics Global is more favorable than its peers.

Insider and Institutional Ownership

25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 48.6% of shares of all “Personal Care Products” companies are held by institutional investors. 7.8% of Prenetics Global shares are held by insiders. Comparatively, 11.7% of shares of all “Personal Care Products” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Volatility and Risk

Prenetics Global has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500. Comparatively, Prenetics Global’s peers have a beta of 0.80, indicating that their average share price is 20% less volatile than the S&P 500.

Profitability

This table compares Prenetics Global and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Prenetics Global -47.43% -21.41% -15.56%
Prenetics Global Competitors -3.85% -62.05% 0.35%

Dividends

Prenetics Global pays an annual dividend of $2.80 per share and has a dividend yield of 27.1%. Prenetics Global pays out -67.3% of its earnings in the form of a dividend. As a group, “Personal Care Products” companies pay a dividend yield of 3.9% and pay out 48.5% of their earnings in the form of a dividend. Prenetics Global is clearly a better dividend stock than its peers, given its higher yield and lower payout ratio.

Valuation & Earnings

This table compares Prenetics Global and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Prenetics Global $154.59 million -$37.71 million -2.49
Prenetics Global Competitors $7.93 billion $1.10 billion 10.20

Prenetics Global’s peers have higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Prenetics Global peers beat Prenetics Global on 8 of the 15 factors compared.

Prenetics Global Company Profile

(Get Free Report)

Prenetics Global Limited is a health sciences company focused on consumer wellness and health-related products. Its portfolio includes IM8, a consumer wellness brand offering nutritional supplements, and CircleDNA, a genetic testing service that provides reports on health, wellness and ancestry. The company has also operated clinical genomic testing services and provided COVID-19 testing during the pandemic. Its business has since shifted toward consumer health and wellness. Prenetics was founded in 2014 and is led by co-founder and Chief Executive Officer Danny Yeung.

Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.